These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9224974)

  • 1. [Immunobiological characterization of murine LB leukemia and the LBC cell line].
    Hajos SE; Mongini C; Waldner C; Sánchez Lockhart M; Gravisaco MJ; Roig I; Fernańdez T; Alvarez E
    Medicina (B Aires); 1996; 56 Suppl 1():45-56. PubMed ID: 9224974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection.
    Mongini C; Sánchez Lockhart M; Waldner CI; Alvarez EM; Gravisaco MJ; Roig MI; Hajos SE
    Br J Cancer; 1996 Jul; 74(2):258-63. PubMed ID: 8688332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and maintenance of T-cell response to a nonimmunogenic murine mesothelioma cell line requires expression of B7-1 and the capacity to upregulate class II major histocompatibility complex expression.
    Leong C; Marley J; Loh S; Robinson B; Garlepp M
    Cancer Gene Ther; 1996; 3(5):321-30. PubMed ID: 8894251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA; Schlom J; Abrams SI
    Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
    Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
    J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
    Rohrer JW; Rohrer SD; Barsoum A; Coggin JH
    J Immunol; 1994 Jan; 152(2):754-64. PubMed ID: 7904290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.
    O'Neill HC; Ni K
    Immunology; 1993 Jun; 79(2):220-8. PubMed ID: 8344701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
    Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
    Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms.
    Chen Z; Rosten SI; Lord EM; Gaspari AA
    Reg Immunol; 1993; 5(5):285-92. PubMed ID: 8148238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2, IL-10, IL-15 and TNF are key regulators of murine T-cell lymphoma growth.
    Gravisaco MJ; Mongini C; Alvarez E; Ruybal P; Escalada A; Sanchez-Lockhart M; Hajos S; Waldner C
    Int J Mol Med; 2003 Oct; 12(4):627-32. PubMed ID: 12964046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo.
    Xiang J; Moyana T
    Cancer Gene Ther; 1998; 5(5):313-20. PubMed ID: 9824051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
    Marzo AL; Lake RA; Robinson BW; Scott B
    Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.